ICAM1 and pulmonary fibrosis: STAT1 antisense oligonucleotides (ASON) could inhibit the secretion of TNF-α and ICAM-1 in alveolar macrophages (AMs), and STAT1 could become a target of treating pulmonary fibrosis (62, 63).